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ABSTRACT 
Objectives: The aim of the study is to review systematic cohort and randomized trials on the relationship between peri-
odontitis and preeclampsia. Periodontitis is an independent risk factor for preeclampsia (PE), and periodontal treatment 
could play a significant role in the prevention of this pregnancy complication. 
Material and methods: A total of 821 items (published until March 2019), thematically related to the relationship between 
periodontitis, its treatment and the incidence of preeclampsia, were collected from the databases of PubMed, Scopus, 
Google Scholar and the Polish Database of Medical Bibliography and analyzed. In the end, 6 cohort studies and 3 rand-
omized controlled trials (from the years 2003–2016) were deemed eligible for the review. The main exclusion criteria were 
as follows: case-control and cross-sectional studies, medical and dental conditions. 
Results: A significant relationship between periodontitis and the risk for developing preeclampsia was demonstrated in 
5 cohort trials, which was not confirmed by only 1 study. A total of 2724 pregnant women, including 195 (7.16%) with PE, 
were analyzed. In 3 randomized trials which assessed the impact of non-surgical treatment (scaling and root planing = SRP) 
on the occurrence of preeclampsia, the preventive effects of the implemented treatment was not confirmed. A total of 
116 women from the group of 1825 pregnant subjects undergoing the non-surgical treatment (SRP) and 116 women from 
the control group of 1827 pregnant women were subsequently diagnosed with PE, which amounted to 6.30% and 6.35%, 
respectively. 
Conclusions: The cohort studies indicated that periodontitis may result in an increased risk for developing PE. A more 
detailed analysis regarding the impact of potential risk factors and modification of further studies (clarification of how 
periodontitis and preeclampsia should be defined in observations, consideration of disease severity, earlier at 12–16 weeks 
of gestation — implementation of the non-surgical treatment, modification and extension of the classical protocol of the 
non-surgical treatment of periodontal diseases, as well as conducting European studies), are necessary due to considerable 
discrepancies in the available literature sources (cohort and randomized observations).
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INTRODUCTION
Periodontitis is a chronic and multifactorial inflammatory 
disease associated with advanced dysbiosis of the patho-
genic bacterial biofilm in periodontal pockets, which leads 
to a progressive destruction of the periodontal attachment 
apparatus. Periodontal pathological processes include high 
biomass of periopathogens (Porphyromonas gingivalis, Tan-
nerella forsythia, Treponema denticola, Aggregatibacter ac-
tinomycemecomitans, Filifactor alocis and Catonella morbi) 
in the biofilm on the root surface, progressive character of 
the inflammatory process in the connective tissue and bone 
resorption of the alveolar ridge, as well as excessive reactivity 
of the host immunological-inflammatory response to the 
bacterial biofilm. Periodontitis is a social disease — the most 
recent nationwide epidemiological study has demonstrated 
that it occurs in approximately 30% of the Polish popula-
tion between the ages of 34 and 45 years [1]. Confirmed 
risk factors include the non-modifiable (age, sex, race and 
genotype) and the modifiable (smoking, poorly controlled 
diabetes, presence of perio-pathogens in the subgingival 
biofilm, poor oral hygiene, obesity and the metabolic syn-
drome, osteoporosis, low social and economic status, stress, 
and poor-quality diet) causes [2]. According to the Polish epi-
demiological reports, periodontitis is diagnosed in 11–12% 
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of all pregnant women [3, 4]. Periodontitis is a risk factor for 
diabetes and a likely risk factor (evidence from case-control 
and cohort studies; no evidence from interventional studies) 
for cardiovascular diseases and their endpoints — myocardial 
infarction, stroke, CVD mortality, low birth weight and/or 
preterm birth, and chronic renal failure [5, 6]. 
Pre-eclampsia (PE) is a hypertensive disorder character-
ized by signs of damage to another organ system, which 
typically develops after 20 weeks of gestation. PE has been 
estimated to occur in 2–8% of all pregnant women and 
is currently considered to be the second main cause of 
maternal and perinatal mortality [7, 8]. The most common 
maternal PE- and hypertension-related complications in-
clude a generalized tonic-clonic convulsion, disseminated 
intravascular coagulation, liver failure and acute renal failure 
with proteinuria, bleeding to the central nervous system and 
retina, HELLP syndrome, congestive heart failure, pulmonary 
edema, placental abruption and cesarean delivery [9]. Fetal 
PE- and hypertension-related complications include the risk 
for admission to the neonatal intensive care unit, intrauter-
ine growth restriction, low birth weight, prematurity, intrau-
terine fetal demise, and early infant mortality [9]. Risk factors 
for PE include: age (> 35 years), race (African-American), 
(family) history of PE, multiple gestation, intrauterine growth 
restriction, obesity, chronic hypertension, pharmacological 
interventions for the induction of the ovulation, pregesta-
tional diabetes mellitus type I or II, gestational diabetes mel-
litus, systemic lupus, and the antiphospholipid syndrome 
[9, 10]. Chronic maternal infections (e.g. urinary tract infec-
tions) are indicators of PE-related risk. In 2002, Riché et al. 
[11], were the first to publish the results of a cohort study 
at Chapel Hill, North Carolina, on the relationship between 
periodontitis and the development of preeclampsia. 
Objectives 
The aim of this systematic review is to present cohort 
and randomized trials on the relationship between perio-
dontitis and preeclampsia. A confirmed role of periodontitis 
as an independent PE-related risk factor would play a vital 
role in the prevention of this obstetrical syndrome. 
MATERIAL AND METHODS
A systematic review of the literature was conducted in 
accordance with the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) [12].
Questions for the review:
1. Do the adjusted odds ratio values indicate an independ-
ent influence of periodontitis on the occurrence of PE 
in cohort studies about the relationship between peri-
odontitis and preeclampsia?
2. Does periodontal treatment significantly reduce the 
incidence of PE?
These questions concerned population-based and 
non-experimental cohort and randomized control trials 
(CCTs or RCTs). 
The review covered all publications in English, German, 
Polish and Russian about the relationship between peri-
odontal diseases and preeclampsia, as well as the influence 
of periodontal treatment on PE-related morbidity.
The inclusion criteria were as follows: pregnancy with 
no PE symptoms before 20 weeks of gestation (blood pres-
sure > 140/90 mm Hg and proteinuria). The exclusion criteria 
included (family) history of PE, incidence of PE in multipa-
rous women, intrauterine growth restriction, pharmacologi-
cally treated hypertension, pharmacologically stimulated 
ovulation, pregestational diabetes mellitus type I or II, ges-
tational diabetes mellitus, systemic lupus, antiphospholipid 
syndrome, and fewer than 10 teeth.
All information was obtained from electronic databas-
es. Electronic searches were conducted in PubMed, Sco-
pus, Google Scholar and the Polish Medical Bibliography 
Databases. All texts were published until the end of March 
2019 were figured in. When searching potential papers, 
the following keywords were used: periodontitis or peri-
odontal disease or periodontal treatment in combination 
with at least one of the following terms: preeclampsia, 
pre-eclampsia, pregnancy outcomes, pregnancy compli-
cations. The obtained articles were subsequently checked 
independently by both authors (TK, AZ) against the inclu-
sion and the exclusion criteria.
The first selection eliminated all the abstracts, case de-
scriptions, reviews, animal studies, in vitro studies and re-
peated publications. Subsequently, the texts of the original 
works were verified against the inclusion criteria (inter alia, 
with the above definitions of preeclampsia and periodontitis 
only in accordance with the clinical probing depth and/or 
clinical attachment loss) and the exclusion criteria (case-con-
trol and cross-sectional studies were excluded). If the trial 
was repeated in the same center, the subsequent study was 
taken into consideration. The relationship between peri-
odontitis and PE (Odds Ratios — ORs) as well as the effect 
of periodontal treatment on the risk for developing PE (Risk 
Ratios — RRs) had to be determined in the studies qualified 
for the review. The decisions of the authors were compared 
at the end of the review and the text was included in the 
analysis only when mutual consensus was reached.
Each study-related entry, independently obtained by 
both authors (TK, AZ), included the name of the author(s), 
year of publication, country of study, sample size, age of 
the examined women, definition of periodontitis, time of 
study, and in case of the periodontal treatment – time of 
treatment and its type, OR (RR) as well as 95% confidence 
interval (CI) values and statistical adjustments for the con-
founding factors. 
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RESULTS
The initial review of the literature identified 821 items 
thematically related to the relationship between periodon-
titis, its treatment and the development of preeclampsia. 
After careful analysis, 16 articles, meeting the inclusion and 
the exclusion criteria, were selected. The last scrutiny ex-
cluded 2 cohort studies conducted previously in the same 
center [11, 13], 3 studies with endpoints which differed from 
the accepted ones [14–16], and 1 study with inadequate 
methodology [17]. In the end, 6 cohort studies [18–23] and 
3 randomized control trials (RCTs) [24–26] were deemed 
eligible for the review. The process of selecting works for 
the systematic review is presented in Figure 1. 
Table 1 summarizes the eligible cohort studies con-
ducted between 2003 and 2016. A significant relationship 
between periodontitis and PE was confirmed by 5 sourc-
es [18, 20–23] and not verified by only 1 [19]. A total of 
2724 pregnant women were assessed, with 195 (7.16%) 
diagnosed with PE. These observations were conducted 
in the USA, India, Korea and Canada. The diversified pool 
of confounding factors, which were being regarded in the 
multi-factor analysis of the modelling process, was strongly 
emphasized.
Table 2 presents 3 randomized studies which assessed 
the impact of non-surgical treatment (scaling and root plan-
ing — SRP) on the morbidity of mothers with PE. None of 
them confirmed the protective effect of the periodontal 
treatment on developing PE. Non-surgical periodontal treat-
ment (removal of subgingival deposits with scaling and root 
planing along with the application of an antiseptic in the 
 Records identied in electronic databases: 
PubMed: 125, Scopus: 134, Google Scholar: 
561, Polish Medical Bibliography: 1  
Total 821  
 
 131 records screened
 
 
 59 full-text articles assessed for eligibility  
 
 
 15 studies met the inclusion criteria
  
 
 
 
Studies included for review
6 cohort studies
3 randomized controlled trials (RCTs)  
 
 
 
  
 
 
Articles excluded with reasons:
Previous study — 2 (11, 13)
Uninteresting outcome3 (14–16)
Methodology — 1 (17)
Third elimination: failure to meet the iclusion
criteria, mainly case-control studies — 44
Second elimination: case and review
articles, language — 72
First elimination: abstracts, duplicated
and irrelevant titles — 690
Figure 1. Flow chart of the study selection process for the systemic review
161
Tomasz Konopka, Aneta Zakrzewska, Periodontitis and risk for preeclampsia — a systematic review
www. journals.viamedica.pl/ginekologia_polska
oral cavity) was performed in 1825 women, out of whom 
116 (6.36%) were subsequently diagnosed with PE. In the 
control group (where only oral hygiene was performed and 
supra-gingival plaque was removed), 116 (6.35%) out of the 
1827 examined women were diagnosed with PE. RCTs were 
carried out only in the USA and Australia. 
DISCUSSION 
It is a well-known fact that cohort and randomized in-
terventional controlled trials have the strongest evidential 
value in establishing a causal relationship between two 
pathologies. Therefore, clinical-control and cross-sectional 
studies were deliberately excluded from this review. The 
relatively high (over 7%) percentage of women with PE in 
the included studies resulted from the fact that the study 
populations comprised non-Caucasian subjects. The co-
hort trials clearly indicated that periodontitis may result in 
an increased risk for developing PE in pregnancy (by 5-fold 
according to some sources). This relationship has also been 
confirmed by all three meta-analyses carried out in this field 
[27–29] so far. In all studies included in the meta-analyses, 
periodontitis was as an independent factor. Sgolastra et al. 
[27], after taking into account 12 clinical-control trials and 
3 cohort studies from 2003–2012 in the random effects mod-
el, obtained the OR at the level of 2.17 (1.38–3.41), although 
with high and significant heterogenicity (only 8 studies con-
firmed the relevance of this relationship). Wei et al. [28], after 
including 13 clinical-control trials and 2 cohort studies from 
2003–2012, using a random effects model, confirmed that 
the probability of developing PE among pregnant women 
with periodontitis was 3-fold higher with respect to gingivi-
tis or healthy periodontium during pregnancy (OR — 2.79, 
CI — from 2.01 to 3.01). A significant heterogeneity among 
these studies has also been demonstrated (13 confirmed 
Table 1. Summary of cohort studies included in the present review
Study/Year Country, city
Sample size, maternal 
age
Definition of 
periodontitis
Time of 
examination
OR 
(95% CI)
Adjustment of 
factors
Boggess et al. [18] 2003 USA Chapel Hill
763 women, 39 with PE 
Age 18–35
PD with 
BoP > 3 mm
1st visit < 26 weeks, 
next 26–36 weeks 
2.4 (1.1–5.3)
For heavy P
Maternal age, race, 
insurance, smoking
Srinivas et al. [19] 2009 USA Philadelphia
786 women, 48 with PE
Mean age 23.9 
PD and 
CAL ≥ 3 mm 
PD and 
CAL ≥ 3 mm 0.71 (0.37–1.36)
Maternal age, race, 
smoking, obesity
Shetty et al. [20] 2010 India Mangalore 
130 women, 30 with PE
Mean age 26.8
PD ≥ 4 mm
CAL ≥ 3 mm
1st visit < 26 weeks, 
next 26–36 weeks 
and within 2 days 
after delivery 
5.78 
(2.41–13.89)
Maternal age, 
education, income 
Kumar et al. [21] 2014 India New Delhi
504 women, 51 with PE
Age 20–35
PD and 
CAL ≥ 4 mm
1st visit 14–18  
weeks, next after 
20 weeks
2.66  
(1.32– 5.73)
Maternal age, 
education, BMI, 
income
Ha et al. [22] 2014 Korea Seoul
283 women, 13 with PE
Mean age 32.8
(25–40)
CAL ≥ 3 mm
1st visit 21–24  
weeks, next after 
26 weeks
4.51  
(1.13– 17.98)
Maternal age, BMI, 
health & oral health 
behaviors
Soucy-Giguère et al. 
[23] 2016
Canada 
Quebec
258 women, 14 with PE
Mean age 35 (19–45) 
PD with 
BoP > 4 mm
1st visit 15–24  
weeks,
next after 26 weeks 
and after delivery
5.89  
(1.24– 28.05) BMI, smoking
Table 2. Summary of intervention studies included in the present systematic review 
Study/Year Country, city
Sample size of the 
study and control 
groups, maternal age
Definition of 
periodontitis
Kind of 
intervention 
Periodontal
treatment time
RR 
(95% CI)
Michalowicz et al. [24] 
2006
USA 
Minneapolis
IG: 407 (31 PE) 
CG: 405 (20 PE)
Mean age 26
PD ≥ 4 mm 
CAL ≥ 2 mm
IG: Hand and 
ultrasonic SRP
Before 21 weeks of 
gestation, monthly 
control
1.54
(0.89– 2.66)
Offenbacher et al. [25] 
2009
USA
San Antonio
Tuscaloosa
IG: 880 (67 PE)
CG:882 (74 PE)
Mean age 25.4 
CAL ≥ 3 mm IG: Hand and ultrasonic SRP
Before 23 weeks of 
gestation, no follow-up 
visits during pregnancy 
0.9
(0.66–1.24)
 Newnham et al. [26] 
2009
Australia
Perth 
IG: 538 (18 PE)
CG: 540 (22 PE)
Mean age 30.5
PD ≥ 4 mm
IG: SRP and 
rinsing with 0.12% 
chlorhexidine 
mouthwash
20–24 weeks of gestation,
28–31 weeks and control 
visit 32–36 weeks
0.82  
(0.44–1.56) 
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the relevance of this association). Also, Huang et al. [29], 
by including 8 clinical-control and 3 cohort studies from 
2003–2013, obtained in their model the OR at the level 
of 2.69 with a 95% confidence interval of 1.74–4.17. Nine 
studies reported a statistically significant relationship be-
tween periodontitis and PE. The subsequent meta-analysis 
demonstrated a significant impact of common risk factors 
(socio-economic status and obesity) on both pathologies, 
and sample size and the quality of the included studies on 
the strength of the relationship. 
The etiopathological mechanisms providing an expla-
nation for the link between periodontitis and PE remain to 
be fully elucidated. However, it seems that the destroyed 
attachment apparatus is the source of direct infection of 
the uteroplacental organ with perio-pathogens. The pres-
ence of Porphyromonas gingivalis, Fusobacterium nuclea-
tum, Aggregatibacter actinomycetemcomitans, Tannerella 
forsythia and Micromonas micros in the placental-fetal unit, 
in chorionic trophoblasts, and in several types of cells such 
as amniotic epithelial, decidual, vascular and in the am-
niotic fluid was demonstrated [30]. Extremely significant 
similarities between the oral cavity microorganisms and the 
placenta were found [30]. On the other hand, inflammatory 
mediators, prooxidative factors, endo- and exotoxins and 
soluble forms of the adhesion molecules, which induce 
inflammation of the uteroplacental area, hypoxia, oxidative 
stress, endothelial dysfunctions leading to PE, penetrate 
into the cardiovascular bed as a result of periodontal in-
flammation [31]. 
From the clinical point of view, reduced incidence of 
PE by modifying the risk factor, in this case the periodon-
tological treatment, is vital. That possibility has not been 
confirmed by previous studies, which seems to contradict 
the presented cohort observations or the aggregated results 
of the clinical-control and cohort studies in the meta-analy-
ses. A meta-analysis of Kunnen et al. [32], based on the same 
three randomized interventional studies characterized in 
Table 2, demonstrates, in the randomized effects model, 
a lack of effect on PE — the overall RR 1.0 (0.78–1.28) with 
respect to no non-surgical treatment of periodontitis be-
ing conducted. This was also confirmed by the subsequent 
meta-analysis of Iheozor-Ejiofor et al. [33], which included 
the 2 described studies [24, 25] and the highly questionable 
study of 2000 — the overall RR was 1.1 (0.74–1.62). Addition-
ally, very poor evidential quality of the combined studies, 
high risk of an error in a publication, and serious imprecision 
were emphasized by the authors. The fact that no protective 
effect of periodontal treatment on the development of PE is 
observed may be explained in two ways. First of all, it should 
be noted that the treatment of periodontitis was performed 
too late to affect the possible development of PE — by way 
of example, in the study by Newnham et al. [26] the treat-
ment was started between 20 to 24 weeks of gestation. 
In the case of an early PE, there is no possibility that such 
treatment will have a preventive effect. Secondly, it remains 
unclear to what extent the classical protocol of non-surgical 
treatment of periodontitis (SRP) during pregnancy protects 
from the exposure to perio-pathogens and proinflamma-
tory biomarkers. Such treatment significantly reduces the 
number of perio-pathogens in the periodontal pockets, but 
it does not eradicate them [34], thus failing to eliminate 
the source of maternal infection. Similarly, such treatment 
does not significantly reduce proinflammatory biomarkers 
in the serum and the umbilical cord blood [35] and, as it 
was indicated in one of the studies, a significant increase 
in serum TNF-α, IL-8 and MCP1 (monocyte chemotactic 
protein) was demonstrated after SRP had been performed 
in pregnant women [36]. If these two suggestions are true, 
then in the subsequent interventional studies, initiation 
of the non-surgical treatment between 12 to 16 weeks of 
pregnancy and improvement of its effectiveness (SRP in 
combination with supplemental antibiotic administration 
or antimicrobial photodynamic therapy) may have some ef-
fect on PE prevalence. However, methodologically improved 
interventional tests in pregnant women should certainly be 
continued, since it is difficult to exclude a positive influence 
of professional periodontal treatment on various complica-
tions of pregnancy.
The present review of the literature about the relation-
ship between periodontitis and preeclampsia is not without 
limitations. Firstly, there are considerable discrepancies in 
the definitions of periodontitis, which also applies to Tables 
1 and 2. However, if only one definition of periodontitis 
were to be selected, this would result in rejecting a majority 
of the analyzed studies. The epidemiological definition of 
CDC (Center for Disease Control and Prevention) and APP 
(American Academy of Periodontology) should be preferred, 
which suggests that at least 2 PD ≥ 4 mm pockets and at 
least 2 CAL ≥ 3 mm spaces on the contacting surfaces are 
required for such a diagnosis. Out of the 9 works analyzed 
in the review, this definition was applied only in one case 
[20]. Stratification of PE severity would also be of great sig-
nificance. Secondly, the definition of preeclampsia should 
also be more precise and differentiated into the early and 
the late PE (with different risk factors), and it should reflect 
the degree of clinical advancement. Thirdly, to the best of 
our knowledge, there are no studies on the subject from Eu-
rope, including Poland. Extrapolating the research results of 
the racially, socio-economically and socio-demographically 
diverse populations to the Polish one is not prudent. This 
applies particularly to intervention studies, which have so 
far been carried out in only two highly developed countries 
— the USA and Australia. The mere diversity of health care 
systems between countries can create numerous barriers 
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for such observations. Next, it is necessary to rigorously 
monitor as many disruptive factors as possible, including, 
in particular, common risk factors for both pathologies: ma-
ternal age, obesity, socio-economic status and smoking. The 
development of clear recommendations on the inclusion of 
these variables in multifactorial analyses in this respect will 
certainly improve the evidence quality of the studies. Finally, 
exclusion of publications in Spanish, typically from South 
America, was a definite limitation.
CONCLUSIONS 
It needs to be emphasized that the relationship be-
tween periodontitis and preeclampsia remains controver-
sial. The existing incompatibility between the cohort and 
randomized trials needs to be further clarified. It is neces-
sary to conduct randomized control trials including Cauca-
sian women, with an accurate effort and attempt to improve 
the methodology. As a result, periodontal treatment would 
not only have a beneficial effect on the quality of patient 
life in relation to oral health, but might also play a role in 
disease prevention, especially PE, which is associated with 
significant morbidity and mortality. PE constitutes a serious 
threat to the health and life of both, the mother and the 
fetus. Thus, any potential modifiable risk factor must be 
clearly established in terms of strength, dose-effect relation-
ship and reversibility. 
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